Vial raises $67 million for clinical trial technology and more funding for digital health

Technology-based contract research organization Vial announced last week that it had raised $67 million in Series B funding.

The round, which the startup says brings its total raise to more than $100 million, was led by General Catalyst with participation from Byers Capital, BoxGroup and other investors.

Vial offers three technology platforms for conducting clinical trials: one for patient onboarding and study initiation, another for data and results capture, and a third focused on participant recruitment. for testing.

“We are proud of what Vial is building: a global, full-service CRO powered by intuitive end-to-end technology aimed at meeting the needs of biotech. Vial is the CRO that sponsors can trust to to be a true partner and meet their needs. Fundraising is the latest exciting step towards executing our mission to reinvent clinical trials,” said Simon Burns, CEO and co-founder of Vial, in a statement.

Ostro, a patient engagement platform formerly known as RxDefine, recently secured $45 million in funding.

The boost came from Founders Fund, Byers Capital, Caffeinated Capital, Greycroft, Bling Capital, Trust Ventures and RRE Ventures, and brought the startup’s total funding to over $55 million.

Ostro offers tools for explaining medical products and drugs to patients, marketing analytics software, and telehealth technologies. The company said the name change reflects its shift from a pharmaceutical approach to one that can be used with medical devices, digital therapies and diagnostics.

Cloud Health Systems, a new startup from Instacart co-founder Apoorva Mehta, recently raised $30 million, according to report by the wall street journal.

The round was led by Thrive Capital with participation from Greenoaks Capital, and it values ​​the startup at $200 million, according to sources seen by the WSJ.

According the WSJthe company will offer consultations and other health services to consumers, initially focusing on metabolic health and obesity.

Digital pathology startup PictorLabs was launched last week alongside a $15.2 million funding round led by M Ventures, SCC Soft Computer and Koç Holding.

The company said the increase brings its total funding to $18.8 million. He is developing a virtual staining platform for histopathology, or the microscopic examination of tissue.

“By virtually staining tissue images in the digital domain, our approach simplifies and accelerates workflows, accelerating drug discovery and diagnostic decision-making with the goal of improving patient outcomes,” said Yair. Rivenson, CEO and CTO of PictorLabs, in a statement. “With the support of our experienced investors, we are now well positioned to systematically expand our platform.”

Minze Health, a Belgian startup specializing in remote monitoring of urinary tract conditions, has raised €3.9 million from White Fund, Capricorn Partners and PMV.

The company said it will use the funding to execute its product development roadmap, conduct studies in Europe and the United States, and focus on international B2B and B2C go-to-market strategies.

“Minze Health’s solutions to often unspoken social problems hold enormous international potential“said Tine Bekaert, chief investment officer at PMV, in a statement.”We are confident that through a unique combination of medical devices with low-threshold and comprehensive diagnostic software, patients worldwide facing urology issues will find their way to this accessible form of home diagnostics. We therefore fully support Minze Health in this crucial phase of international expansion.”

Hopelab announced on Monday that it has invested $1.5 million in five startups that provide mental health care: brave health, Caraway HealthInStride, MindRight Health and Violet.

The investor said the funding is focused on improving access to care, especially for youth of color and LGBTQ+ youth.

“Young people today are experiencing heightened stress like never before, and this is where our partnerships can have a real impact,” Erin Sietstra, chief investment officer at Hopelab, said in a statement. “We are constantly striving to improve the mental health and well-being of young people, especially among LGBTQ+ and BIPOC young people, and invest in new digital solutions led by entrepreneurs who personally understand the gaps in health care. will promote better well-being for this generation and generations to come.”

Leave a Reply

Your email address will not be published. Required fields are marked *